To The Moon

$Ensign(ENSG)$ $WELLTOWER OP LLC(WELL)$  $Omega Healthcare Investors(OHI)$  🚑📈💰 Ensign Group $ENSG Breaks Out On Earnings Execution, Guidance Ignites Re-Rating 💰📈🚑

I’m watching Ensign Group dominate Nasdaq action following a powerful earnings reaction that pushed the stock to fresh all-time highs and delivered its strongest single-day performance in more than five years. Momentum, guidance strength, and institutional flow aligned perfectly.

📊 Price Action Explosion

I’m seeing $ENSG trading around $194.7 after ripping roughly +12.3% on the session, briefly tagging a record $199.01 intraday. The move decisively cleared prior resistance, forcing under-positioned funds to chase and shifting the stock from consolidation back into expansion mode.

📈 Q4 Earnings Breakdown

I’m focused on the quality of execution, not just headline numbers.

• Adjusted EPS: $1.82, beating expectations and up +22.15% YoY from $1.49

• Revenue: $1.36B, up +20.23% YoY from $1.13B

• EPS surprise reflected margin expansion and operational strength

• Revenue variance was marginal, around -0.7% versus some forecasts, but profitability momentum dominated the reaction

Execution strength, not revenue optics, drove the market response.

🚀 Guidance That Triggered The Re-Rating

Management delivered the real catalyst.

• 2026 EPS guidance: $7.41 to $7.61

• 2026 revenue outlook: $5.77B to $5.84B

• Assumes continued acquisitions, facility optimisation, and stable reimbursement conditions

This guidance locks in forward visibility and confirms management still sees expansion runway across skilled nursing and rehab operations.

🏥 Operational Engine Driving Growth

I’m looking at Ensign not as a one-quarter spike, but as a structural compounder.

Same-facility occupancy reached an all-time high near 83.8%, while transitioning operations ran even stronger. Skilled mix continued expanding across Medicare and managed care channels, supporting margin improvement.

Operational quality also stands out, with CMS surveys showing Ensign facilities outperforming peers across state and county rankings, reinforcing asset quality and competitive positioning.

Growth momentum remains active operationally too.

• 51 operations added during 2025

• 17 added in Q4 alone

• Multiple new Texas operations effective February 1

• Real estate acquisitions continue supporting long-term margin leverage

Their model remains consistent: acquire underperforming facilities, optimise operations, expand margins, reinvest cash flows, then repeat the cycle.

📉 Technical & Institutional Flow Perspective

I’m reading this as a structural breakout supported by conviction flow, not just momentum chasing.

• Price cleared prior highs decisively

• Volume expansion confirmed participation

• Former resistance now likely acts as support on pullbacks

• Funds continue rotating toward profitable healthcare compounders

Momentum plus earnings plus guidance plus institutional rotation rarely align without continuation potential.

🧠 What I’m Watching Next

I’m tracking whether price holds above the breakout zone in coming sessions. If consolidation holds instead of reversing, this could mark the start of another multi-month advance leg.

Healthcare operators delivering both growth and margin expansion continue to attract premium valuations when forward guidance confirms expansion runway.

Ensign just reminded the market why consistent operators earn valuation re-ratings.

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀

@Tiger_comments @Tiger_Earnings @TigerStars @TigerObserver @TigerPicks @TigerWire @Daily_Discussion